The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2
about
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chainStructure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptorA post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligandStructure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivAn N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivoTypes of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated dataPEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligandsHLA-B27 misfolding and ankylosing spondylitisDisabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptideHLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine releasePatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesPoor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptideThe structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexesClass I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contactsT cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surfaceStructural Basis of Cytochrome c Presentation by IE kAlternate interactions define the binding of peptides to the MHC molecule IA(b).HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterationsA structural basis for immunodominant human T cell receptor recognitionCrystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptorA T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeCa2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed selfConformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificityIdentification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A virusesNarrow Groove and Restricted Anchors of MHC Class I Molecule BF2*0401 Plus Peptide Transporter Restriction Can Explain Disease Susceptibility of B4 ChickensCrystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding grooveCrystal structure of the complex between human CD8alpha(alpha) and HLA-A2The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain.Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligandsCrystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl groupStructural evidence of T cell xeno-reactivity in the absence of molecular mimicryIdentification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensorsThe transporter associated with antigen processing: function and implications in human diseasesChemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of ImmunodominanceAlthough divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoiresThe antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.Peptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.A continuous peptide epitope reacting with pandemic influenza AH1N1 predicted by bioinformatic approaches.
P2860
Q24309337-EA04FFD7-04A9-47BA-A5F5-50A5E625BB89Q24563048-29A4AFE4-49DB-4C0B-A63D-DD1C495B4EF6Q24671977-2452D04D-B0DB-4AD2-9FFD-B3FFF59BB231Q24672491-80B6CA99-7D77-4B8D-8E5C-15E3C63F4887Q24673986-255B9764-3403-4CB4-8549-850F6AC7F3E3Q24676272-0885AB84-665B-41CA-AACE-BF5B6C488430Q24793027-80D00A43-72C1-4B72-9B84-2B49424EA173Q24812058-888FD206-EBB2-4D08-9601-7ECB98FD1844Q26860818-CBFB82B8-86A1-4DB3-ABE4-C78886DACCB3Q27473483-A040EC91-9C37-4022-AC1C-28AFE42E96B6Q27478341-A615F7C9-DF96-4976-8B0F-DCF4E7BEFD2EQ27478466-E881A63F-EE1B-4B15-987A-2F93ADC75C69Q27620636-9998CB76-EB46-432C-8C66-B7439B42998CQ27620750-778159A9-B9AA-4DEC-93EC-E75FECBD11D1Q27631018-3A6E33F9-650E-4C6D-9205-E7EE02626143Q27635182-EC567123-7469-402C-BE5D-41915D346216Q27638866-68CEAEB2-99FE-4813-8479-993EE488D109Q27639260-A8873501-FF61-4CC2-AD4D-33011F7C4BCEQ27639674-A5C11117-219F-42A4-9363-E6CC97400E65Q27641421-B96880AE-9E49-4643-B04E-B5707FD813B7Q27641776-1A53C347-C35F-4DBE-A1E4-6CC73A0C4003Q27643687-0D62CC47-64BA-448B-B407-1F0F4CCA4C99Q27646628-7C5E41CA-478D-4731-9F24-CBC4902A0B42Q27652421-5A143DE1-5C80-40F6-9512-54D1275353BDQ27653583-02FAFDDD-B882-4AE6-BC5D-8F1744298877Q27658413-33580AFE-226A-438C-807A-6D5A23E19448Q27674278-5F795A56-A29C-43AC-8AD8-CF7E4EF34E56Q27729958-F83DCB3B-B239-4534-9349-388CAE9361B5Q27738835-7D09626F-3135-4E98-8D74-148122570CA8Q27741302-5034A7E1-1199-4534-8057-5D11A09E6051Q27765141-58BE7F8D-1CAB-4C11-A7BB-90E86E7CFCC1Q27765349-5C322C61-827B-4173-9E40-C9188EC82260Q27766708-D4E0EBD1-6447-4CB3-960F-5C27C4FF2E06Q28187967-DFC648BF-4274-49CF-9023-66725A06A673Q28214433-CBDB2EAA-FF03-4AE6-8787-31D202496256Q28552025-6B555A5C-0BE3-47CF-AAF1-61C708F5D22DQ28743226-E64DD38B-5715-4888-8C2A-C7A84E19EDA7Q30252521-C2CAC1C1-EE2A-470E-8216-AD7BD30534D4Q30351955-16FB5B32-0000-42BE-97C8-B0E095679551Q30372843-B42FF9B2-0A7C-44DC-BAAA-F8289F467B4F
P2860
The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The antigenic identity of pept ...... l peptides presented by HLA-A2
@ast
The antigenic identity of pept ...... l peptides presented by HLA-A2
@en
The antigenic identity of pept ...... l peptides presented by HLA-A2
@nl
type
label
The antigenic identity of pept ...... l peptides presented by HLA-A2
@ast
The antigenic identity of pept ...... l peptides presented by HLA-A2
@en
The antigenic identity of pept ...... l peptides presented by HLA-A2
@nl
prefLabel
The antigenic identity of pept ...... l peptides presented by HLA-A2
@ast
The antigenic identity of pept ...... l peptides presented by HLA-A2
@en
The antigenic identity of pept ...... l peptides presented by HLA-A2
@nl
P2093
P3181
P1433
P1476
The antigenic identity of pept ...... l peptides presented by HLA-A2
@en
P2093
D N Garboczi
D R Madden
P304
P3181
P356
10.1016/0092-8674(93)90490-H
P407
P577
1993-11-19T00:00:00Z